The Government will task regulatory watchdog The Council for Healthcare Regulatory Excellence (CHRE) to review the RPSGB’s handling of complaints, following concerns raised in a House of Commons report.

Responding to the House of Commons Science and Technology Committee’s evidence check on homeopathy, the Government said it would request CHRE review the Society’s “handling of complaints in terms of both thoroughness and timeliness.”

The move follows comments in the Science and Technology Committee report, published in February, which expressed concern about the length of time of RPSGB investigations. The report urged the Government to enquire whether the RPSGB “is doing an adequate job in respect of time taken to pursue complaints.”

The General Pharmaceutical Council has already undertaken a due diligence review of the fitness to practise cases it will inherit, the Government added.